Radius Health Inc. (RDUS)

15.95
NASDAQ : Health Technology
Prev Close 15.95
Day Low/High 0.00 / 0.00
52 Wk Low/High 14.52 / 41.16
Avg Volume 795.90K
Exchange NASDAQ
Shares Outstanding 45.54M
Market Cap 721.35M
EPS -5.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CART, III, PDVW, PFMT, RCM, TD Downgrades: HCAP, HOME, SFLY, SNFCA, TATT Initiations: AEYE, ATUS, MYO, RDUS, TDW, VNTR Read on to get TheStreet Quant Ratings' detailed report:

Relative Strength Alert For Radius Health

Relative Strength Alert For Radius Health

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of RDUS April 2019 Options Trading

First Week Of RDUS April 2019 Options Trading

Investors in Radius Health Inc saw new options become available this week, for the April 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

First Week Of August 17th Options Trading For Radius Health (RDUS)

First Week Of August 17th Options Trading For Radius Health (RDUS)

Investors in Radius Health Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Radius Health Initiates Phase 3 Clinical Trial Of Abaloparatide Injection For The Treatment Of Male Osteoporosis

Radius Health Initiates Phase 3 Clinical Trial Of Abaloparatide Injection For The Treatment Of Male Osteoporosis

Bridging study will evaluate change in spine bone mineral density (BMD) at 12 months compared with placebo

Interesting RDUS Put And Call Options For May 18th

Interesting RDUS Put And Call Options For May 18th

Investors in Radius Health Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Square, Manitowoc, FMC Corp: 'Mad Money' Lightning Round

Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

It's Bad, but It's Not a Crash: Cramer's 'Mad Money' Recap (Friday 2/2/18)

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

First Week of RDUS March 16th Options Trading

First Week of RDUS March 16th Options Trading

Investors in Radius Health Inc saw new options begin trading this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

Interesting RDUS Put And Call Options For February 2018

Interesting RDUS Put And Call Options For February 2018

Investors in Radius Health Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RDUS options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

Erytech Pharma Plummets on Phase 2 Data -- Biotech Movers

France-based firm said its Phase 2 study of eryaspase (Graspa) in acute myeloid leukemia did not achieve its primary endpoint of overall survival.

TheStreet Quant Rating: D- (Sell)